Forex ziņas

Soft Start Seen For Taiwan Stock Market

The Taiwan stock market on Tuesday ended the six-day winning streak in which it had surged almost 400 points or 2.3 percent. The Taiwan Stock Exchange now sits just above the 17,850-point plateau and it's likely to open under pressure again on Wednesday.
RTTNews | 587 days ago
Singapore Shares Tipped To Open In The Red

Singapore Shares Tipped To Open In The Red

The Singapore stock market on Tuesday ended the three-day winning streak in which it had risen almost 100 points or 3 percent. The Straits Times Index now sits just beneath the 3,230-point plateau, although it's doe for profit taking on Wednesday.
RTTNews | 587 days ago
Malaysia Shares May Take Further Damage On Wednesday

Malaysia Shares May Take Further Damage On Wednesday

The Malaysia stock market has finished lower in back-to-back sessions, slipping almost 5 points or 0.3 percent in that span. The Kuala Lumpur Composite Index now sits just shy of the 1,455-point plateau and the losses may accelerate on Wednesday.
RTTNews | 587 days ago
Tech Shares Likely To Drag KOSPI Lower

Tech Shares Likely To Drag KOSPI Lower

The South Korea stock market has climbed higher in four straight sessions, advancing more than 70 points or 2.7 percent along the way. The KOSPI now rests just shy of the 2,670-point plateau and investors are likely to cash in on Wednesday.
RTTNews | 587 days ago
U.S. Dollar Starts New Year On Upbeat Note

U.S. Dollar Starts New Year On Upbeat Note

Following a disappointing final month of 2023, the value of the U.S. dollar showed a strong move to the upside to start the new year. The advance by the dollar may reflect its appeal a safe haven, as Middle East tensions escalated after U.S. helicopters repelled an attack on Sunday by Iran-backed Houthi militants on a Maersk container vessel in the Red Sea.
RTTNews | 587 days ago
more news
Allorion Therapeutic Inks Agreement With AstraZeneca  For EGFR L858R Allosteric Inhibitor Program

Allorion Therapeutic Inks Agreement With AstraZeneca For EGFR L858R Allosteric Inhibitor Program

Allorion Therapeutics, a US and China-based biotechnology company, on Tuesday entered into an exclusive option and global license agreement with British drug major AstraZeneca plc (AZN) to develop and commercialize a novel epidermal growth factor receptor (EGFR) L858R mutated allosteric inhibitor, as a potential new treatment for advanced EGFR-mutant non-small cell lung cancer (NSCLC).
RTTNews | 588 days ago
Pound Drops As U.K. Manufacturing Downturn Intensifies

Pound Drops As U.K. Manufacturing Downturn Intensifies

The pound weakened against its major counterparts in the European session on Tuesday, as the nation's manufacturing activity contracted at a faster pace in December as output fell sharply amid weaker demand conditions both domestically and internationally.
RTTNews | 588 days ago

Stay up to date!

Add Ziņas to your browser

Extension Picture